John Glenn - 15 Dec 2022 Form 4 Insider Report for IRADIMED CORP (IRMD)

Reporting relationship: Chief Financial Officer
Issuer ticker: IRMD
Reported as of: 15 Dec 2022
Net transaction value: +$71,676
SEC form: 4
Accepted by SEC: 16 Dec 2022, 12:10:47 UTC
Prior SEC filing: 09 Dec 2022
Next SEC filing: 22 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ John Glenn

Key filing fact

John Glenn filed Form 4 for IRADIMED CORP (IRMD) on 16 Dec 2022.

Key facts

This page summarizes John Glenn's Form 4 filing for IRADIMED CORP (IRMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Dec 2022, 12:10.

Change

Previous filing in this sequence was filed on 09 Dec 2022.
Current net transaction value: +$71,676.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRMD transaction

Common Stock

Award

Transaction value: $71,676
Shares: +2,500
Change %
Price: $28.67
Shares after: 2,500
Date: 15 Dec 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple trades at prices ranging from $28.61 to $28.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.